The efficacy of DTI MRI scans in English personal injury litigation: A critical analysis

Warren Collins, Partner at Penningtons Manches Cooper LLP and Pankaj Madan, Barrister at Exchange Chambers and 12 King’s Bench Walk, take a look at the use of imaging in the court.

Diffusion Tensor Imaging (DTI) represents a significant advancement in Magnetic Resonance Imaging technology, offering unprecedented insights into the microstructural integrity of white matter tracts in the brain. In the context of English personal injury litigation, DTI has emerged as a potentially powerful tool for detecting and quantifying  traumatic brain injuries (TBI) that may not be visible on conventional MRI scans.

However, the adoption of DTI in legal proceedings has been met with both enthusiasm and scepticism, raising important questions about its reliability, admissibility, and practical utility in the courtroom.

This article examines the current state of DTI technology in personal injury cases within the English legal system, analysing its strengths and limitations while considering the evolving judicial approach to novel medical evidence.

Understanding DTI Technology

Warren Collins

DTI is an advanced neuroimaging technique that measures the diffusion of water molecules along bundles of neural pathways. In simple terms, the time it takes water molecules to diffuse is longer for damaged bundles of neural fibres compared to normal undamaged tracts . A precise measurement of the diffusion time therefore reveals damaged tracts.

Unlike conventional MRI, which primarily shows anatomical structure, DTI provides information about the microscopic organisation of brain tissue. The technique measures fractional anisotropy (FA) and mean diffusivity (MD), which can indicate damage to white matter tracts even when structural abnormalities are not apparent on standard imaging. Even the most powerful MRI scanners cannot image damaged neuronal tracts. They are very good at detecting micro-heamorrhaging.

The technology’s ability to detect subtle changes in brain connectivity has made it particularly attractive in cases involving mild traumatic brain injury (mTBI) or concussion, where traditional imaging often appears normal despite persistent symptoms. DTI can potentially demonstrate objective evidence of brain injury in cases where claimants report cognitive and emotional difficulties, memory problems, or other neurological symptoms following trauma.

Clinical Applications and Limitations

From a clinical perspective, DTI has shown promise in research settings for identifying white matter abnormalities associated with various neurological conditions. Studies have demonstrated correlations between DTI metrics and cognitive function, suggesting that the technology can provide meaningful information about brain health and injury. However, several significant limitations must be acknowledged. DTI measurements can be influenced by numerous factors including age, sex, education level, and pre-existing conditions. The technology requires sophisticated analysis and interpretation, and there is currently no universally accepted threshold for determining what constitutes abnormal DTI values. Furthermore, the clinical significance of many DTI findings remains unclear, particularly in terms of their relationship to functional outcomes and symptom severity.

The variability in DTI results between different scanners, acquisition protocols, and analysis methods also presents challenges for standardisation. This technical complexity raises questions about the reproducibility and reliability of DTI findings, particularly when used as evidence in legal proceedings.

Legal Framework and Admissibility

In English courts, the admissibility of expert evidence is governed by the Civil Procedure Rules and established case law, particularly the principles established in Daubert v. Merrell Dow Pharmaceuticals (though this US case has influenced rather than bound English courts) and the English authorities on expert evidence reliability.

The English approach to novel scientific evidence has evolved significantly, with courts applying increasingly rigorous standards for admissibility. Under Part 35 of the Civil Procedure Rules expert evidence must be either “necessary” (no proportionality test) or “reasonably required” (a proportionality test applies however). The guidance in cases such as Jones v Kaney [2011] UKSC 13, is that expert evidence must be reliable, relevant, and within the expert’s area of competence. The established view in Kennedy v Cordia (Services) LLP UK [2016] UKSC 6 at paragraphs 39 and 45  is that expert evidence is  required if it will assist the Court on issues where it cannot form its own conclusions without help.

How have the English Courts treated CT and MRI scanning?

Siegel v Pummell [2014] EWHC 4309 QB

Here, the Court in 2014 ruled that DAI could exist on a microscopic level even If not shown on an MRI scan. Mr Justice Wilkie rejected “the Defendant’s contention that in the absence of evidence of a head injury in the form of: no loss of consciousness; a normal Glasgow Coma Scale; and an absence of evidence if lesions from CT and MRI scans; a DAI is conclusively ruled out. In my judgment, there are a number of factors pointing towards there having been a DAI on the microscopic level, as described by Dr Allder and in the literature upon which he relies.”

Hibberd-Little v Emily Carlton [2018] EWHC 1787

In this case, the Claimant was involved in a rear end collision road traffic accident. The claimant’s evidence was “after the accident everything changed. I always seemed to be tired and my brain just didn’t seem to function in the way it had before … I no longer seemed to be able to handle the pressure of the (teaching) job and I started to find it stressful, believing that it was only a matter of time before I was found out and sacked.“ While the claim was of relatively modest value, the trial judge nevertheless criticised the lack of scanning evidence and found “I understand that Dr. Allder’s position is that because DAI, especially microscopic DAI, is not likely to show on scans there is nothing to be gained by scanning, however state of the art the scanning might be. This strikes me as putting the cart before the horse. Given that the academic authors recognise that DAI is a ” diagnosis of exclusion ” it would have been helpful to have imaging results in this exclusionary process, particularly if scanning had become more sophisticated in the 10 years between 2003 and the accident (and I accept Dr. Heaney’s evidence that it had). There is even a possibility that imaging would reveal other potential causes for the claimant’s enduring symptoms. It could in my judgment have forestalled the line of questioning about whether damage to the fornix was at the heart of the claimant’s neuro-pathway problems. That might explain her condition (damage to the fornix being something that would have been more likely to show on imaging). Had there been imaging results, they may have been negative or neutral for microscopic DAI. That would not have been the end of the claimant’s case. However, I conclude that the absence of imaging results begins to undermine the submission made on behalf of the claimant that her experts have engaged in “rigorous [exclusionary] methodology” in reaching the diagnosis they have.”

Palmer v Mantas [2022] EWHC 90

Here the Court found that the lack of findings on CT and standard MRI imaging was not a bar to a finding of a finding of TBI but the Defendant’s argument to the contrary may well have fallen away had the Claimant also adduced more sophisticated scanning in evidence.

Stansfield v BBC [2021] EWHC 2638

In this well publicised case involving the BBC “Bang Goes the Theory” presenter Jeremy Stansfield, the trial judge observed “Dr Heaney, highlighted that the claimant had undergone six MRI scans over a period of two and a half years, all of which show no damage. He said it was also significant that there was no evidence of brain atrophy. However, he acknowledged that the scans could not exclude a mild brain injury. His evidence was that the scans provided an important piece of evidence pointing against there being a traumatic brain injury. In the joint statement, the claimant’s expert, Dr Sekhar, had pointed out that it was a limitation of the neuroradiology evidence that the first scan did not occur until two years after the crash tests. In court, he stressed that not all diffuse axonal injuries are captured radiologically. Having heard what both neurologists said, I conclude that the radiological evidence is an important piece of evidence against traumatic brain injury which must be put in the balance. However, it is in no way conclusive….” But went on to say that “..the absence of any radiological findings and of clear evidence of PTA are very important factors which point against traumatic brain injury. These factors are to be given significant weight.”

All of these cases may suggest that a Claimant  with classic symptoms of a traumatic brain injury may be taking an evidential gamble when proceeding with a claim where CT or MRI scanning do not show any organic injury to the brain. This is where MRI with DTI scanning may have a valuable role to play in the litigation process.

For DTI evidence to be admissible in English personal injury litigation, several criteria must be satisfied:

• Relevance: The evidence must be relevant to the issues in dispute. DTI’s ability to detect microstructural brain damage makes it potentially relevant in cases involving suspected brain injury where conventional imaging appears normal.
• Expert Qualification: The expert providing the evidence must be suitably qualified. This typically requires specialist expertise in neuroimaging, neurology, or neuroradiology, with specific experience in DTI interpretation.
• Scientific Reliability: The underlying science must be sufficiently reliable. Courts will consider factors such as peer review publication, known error rates, and general acceptance within the relevant scientific community.
• Proportionality: Under the Civil Procedure Rules, the court must consider whether the potential value of DTI evidence justifies its cost and complexity, particularly in cases where other evidence may be sufficient.

While DTI technology has been increasingly discussed in legal circles, the clinical use of DTI to identify white matter abnormalities in the brain at the chronic stage is considered by a responsible body of medical opinion (the “Bolam” test) to be  a valid methodology both clinically as well as forensically and should be and in the experience of the authors is being admitted into evidence in personal injury proceedings if supported by a neurologist and interpreted by a competent neuro-radiologist. For example see the recent open source article by Lindblom et al “Association of Cognitive-linguistic deficits to diffusion tensor imaging parameters in moderate to severe traumatic diffuse axonal Injury”  Applied Neuropychology: Adult 2025 Vol 21, No 1 338-345.

However, we are yet to see any reported decisions specifically on the legal evidential reliability or otherwise of DTI scanning the English Courts. This reflects several realities of the English legal system: most personal injury cases settle before trial, county court decisions are not always comprehensively reported, and detailed evidentiary rulings may not be published even when cases proceed to judgment. The absence of extensively reported DTI cases should not be interpreted as judicial rejection of the technology. Instead, it likely reflects the relatively recent development of DTI as a litigation tool and the fact that many brain injury cases are resolved through settlement negotiations where the potential admissibility of DTI evidence may influence settlement values without requiring formal judicial determination.

Where DTI evidence has been considered, several factors appear to influence judicial attitudes. Courts are highly likely to require that DTI is presented only as part of a comprehensive medical assessment by a competent neuro-radiologist and neurologist rather than as a standalone diagnostic tool. The quality of expert evidence  is crucial, with courts placing significant weight on the expertise and credibility of the  neuro-radiologist and  neurologist interpreting the scans.

The presentation of DTI evidence must also be balanced and acknowledge the technology’s limitations. Experts who oversell the capabilities of DTI or fail to discuss alternative explanations for findings may find their evidence given less weight or excluded entirely. This approach aligns with the broader judicial trend toward more rigorous scrutiny of expert scientific evidence.

Practical Considerations for Legal Practitioners

Pankaj Madan

For solicitors and barristers handling personal injury cases involving potential brain injury, several practical considerations arise when considering DTI evidence. The cost of DTI scanning and expert analysis can be substantial, and is and virtually all litigation is now conducted with the Solicitors firm bearing the upfront costs under a conditional fee agreement often with the assistance of a medical agency. The timing of DTI scanning is also important, as changes in brain tissue may evolve over time following injury.

Legal practitioners must carefully consider whether DTI evidence will genuinely advance their case. In some instances, the additional complexity and cost may not be justified, particularly where other evidence clearly establishes the extent of injury and its consequences. However, in cases where conventional imaging is normal but neurological symptoms persist, DTI may provide crucial objective evidence of brain injury.

The selection of appropriate experts is critical. Radiologists specialising in neuroimaging, neurologists withexpertise in traumaticbrain injury, and neuropsychologists familiar with DTI interpretation are likely to have the relevant expertise. The expert’s ability to communicate complex technical concepts to a Judge  is equally important.

Challenges and Controversies

We are bound to encounter challenges to the use of DTI in personal injury litigation. The technology’s relative novelty means that long-term outcome data is limited, making it difficult to establish clear correlations between DTI findings and functional impairment. This limitation is particularly significant in legal contexts where damages may be awarded based on long-term prognosis.

The potential for false positives and false negatives also presents challenges. DTI abnormalities may be present in asymptomatic individuals, while some people with clear symptoms may have normal DTI scans. This complexity requires careful interpretation and contextualisation of results.

There is also ongoing debate about the appropriate statistical methods for analysing DTI data and the significance of group-level versus individual-level findings. Many research studies report group differences that may not be applicable to individual cases, raising questions about the translation of research findings to clinical and legal contexts.

Future Developments

The field of DTI continues to evolve rapidly, with improvements in scanning technology, analysis methods, and understanding of the relationship between DTI metrics and clinical outcomes. Advanced techniques such as multi-shell diffusion imaging and connectome analysis may provide even more detailed information about brain connectivity and injury.

Standardisation efforts are underway to improve the reliability and reproducibility of DTI measurements. The development of normative databases and standardised protocols may help address some of the current limitations in clinical and legal applications.

Machine learning and artificial intelligence approaches are also being applied to DTI analysis, potentially improving the accuracy and consistency of interpretation. However, these developments also raise new questions about the explicability and reliability of automated analysis methods.

Recommendations for Practice

Based on current evidence and legal precedent, several recommendations emerge for the use of DTI in English personal injury litigation: DTI should be considered as part of a comprehensive medical assessment rather than a standalone diagnostic tool. The technology is most valuable when used to corroborate clinical findings and support a coherent narrative of brain injury and its consequences.

Legal practitioners should ensure that DTI evidence is presented by appropriately qualified experts who can discuss both the strengths and limitations of the technology. The expert should be familiar with the specific DTI protocols used and able to explain the significance of findings in the context of the individual case.

Courts should be provided with clear information about the reliability and limitations of DTI evidence. This includes discussion of factors that may influence results, the significance of any abnormalities found, and the relationship between DTI findings and functional outcomes.

The timing and context of DTI scanning should be carefully considered. Scans performed too early after injury may not capture the full extent of damage, while those performed too late may be complicated by other factors such as treatment effects or natural recovery processes.

Conclusion

DTI MRI scanning represents a significant advancement in neuroimaging technology with considerable potential for detecting and quantifying brain injury in personal injury cases. However, the technology’s efficacy in English litigation may remain limited by several factors including technical limitations, interpretative challenges, and the current state of scientific knowledge.

The successful use of DTI evidence in personal injury litigation requires careful consideration of its strengths and limitations, appropriate expert evidence, and judicial understanding of the technology’s capabilities and constraints. As the science continues to evolve and courts become more familiar with DTI evidence, its role in personal injury litigation is likely to expand.

Legal practitioners considering DTI evidence must weigh the potential benefits against the costs and limitations, ensuring that the technology is used appropriately to support rather than replace traditional medical assessment and expert testimony.

The future of DTI in personal injury litigation will depend on continued scientific advancement, improved standardisation, and the development of clearer guidelines for clinical and legal applications.

The integration of DTI into personal injury practice represents part of a broader trend toward more sophisticated medical evidence in litigation. As courts become increasingly comfortable with complex scientific evidence, the standards for admissibility and interpretation will continue to evolve, requiring ongoing education and adaptation by legal practitioners, medical experts, and the judiciary alike.